Sanofi Is Looking at New Compounds to Expand MS Business

Sanofi, which bought Genzyme last year, is seeking new treatments to expand its multiple sclerosis business, said Michael Panzara, Genzyme’s therapeutic area head for multiple sclerosis, immune diseases and neurology.
Bloomberg